Swedbank
XENE icon

Swedbank’s Xenon Pharmaceuticals XENE Stock Holding History

Swedbank’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.06M Buy
82,300
+6,000
+8% +$356K ﹤0.01% 608
2026
Q2 		$4.61M Buy
76,300
+50,100
+191% +$2.78M ﹤0.01% 590
2026
Q1 		$1.52M Buy
+26,200
New +$1.21M ﹤0.01% 648

Other funds holding XENE

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Oak Ridge Investments
Oak Ridge Investments Chicago, Illinois $1.68B AUM 48.52% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Swedbank's XENE Position: Q3 2026 in Review

Swedbank increased its Xenon Pharmaceuticals (XENE) stake by 7.9% in Q3 2026, buying an estimated $356K and bringing the position to 82,300 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Swedbank first reported a position in XENE in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.61M in Q2 2026. 47 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Swedbank held 82,300 shares of Xenon Pharmaceuticals worth $3.06M as of Q3 2026.
  • Swedbank bought 6,000 Xenon Pharmaceuticals shares in Q3 2026, an estimated $356K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Swedbank's portfolio in Q3 2026, its #608 holding.
  • Swedbank first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Swedbank's Xenon Pharmaceuticals position peaked at $4.61M in Q2 2026.
  • 47 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.